Metropolis Healthcare Limited (METROPOLIS) Share Price
NSE · Healthcare · Diagnostics & Research · ISIN INE112L01020
Key metrics
- Market Cap
- ₹12,075 Cr
- P/E Ratio
- 59.84
- EPS
- 9.73
- Book Value
- 73.53
- P/B Ratio
- 7.92
- ROE
- 12.46%
- ROCE
- 16.98%
- Debt / Equity
- 0.15
- Net Margin
- 11.55%
- Revenue Growth
- 23.64%
- Profit Growth
- 31.08%
- Dividend Yield
- 0.34%
- 52W High
- ₹609.05
- 52W Low
- ₹412.25
- Market Cap Band
- mid cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Metropolis Healthcare Limited
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India and internationally. The company offers routine and specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; clinical trial research, hospital lab management, and home collection services; radiology services, including X-ray, sonography and ECG; and next-generation sequencing services. It also provides diagnostic services for oncology, chronic and infectious diseases, gastroenterology, neurology, nephrology, and women and child health, as well as various health checkup and laboratory services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, mobile app, website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 4,484
- Promoter Holding
- 47.84%
The full Metropolis Healthcare Limited analysis
Create a free account to open the complete METROPOLIS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.